ホーム > 市場調査レポート > 医薬品 > 製薬企業関連 > 医薬品市場セグメンテーション:投資、戦略、および導入
カテゴリ
医薬品 (4955)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (182)
感染症 (351)
規制環境 (130)
後発医薬品 (134)
骨疾患 (37)
処方薬 (157)
神経疾患 (174)
精神疾患 (88)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

医薬品市場セグメンテーション:投資、戦略、および導入

Pharmaceutical Market Segmentation: Spending, Strategy and Implementation

発行 Cutting Edge Information
出版日 2006年07月 商品コード 41836
ページ情報 英文 132 Pages
価格
こちらの商品の販売は終了いたしました。

当商品の販売は、2011年12月09日を持ちまして終了しました。

原文目次

Abstract

Cutting Edge Information has developed this study to research pharmaceutical market segmentation and how companies use it to their advantage. Pharmaceutical Market Segmentation examines market segmentation budgets, structures, staffing, strategies and implementation to teach you how enact new or improve existing segmentation plans. From leadership to spending to sales team implementation, this report details some of the industry' s top companies' segmentation strategies.

Cutting Edge Information' s report Pharmaceutical Market Segmentation analyzes market segmentation metrics and strategies from some of the industry' s top companies to provide all the steps necessary to improve market segmentation and offer purchasers benchmarks for excellence.

The report makes its case with market segmentation metrics and techniques in three chapters:

  • Market Segmentation Budgets, Structure and Staffing - Details brand-level overall market segmentation budgets, as well as physician and consumer segmentation spending. Also examines participants' market segmentation structures and staffing.
  • Market Segmentation Strategy - Examines the various techniques for segmenting markets and provides real companies' rankings for and reactions to each technique.
  • Implementing and Reviewing Market Segmentation Strategies - Explains how top companies convey segmentation strategy and importance to their sales forces. Explores how these same companies ensure that they have the full buy-in of the sales force and that segmentation is working. Finally, the chapter discusses how often and in what way companies review their segmentation strategies after a product is launched.

Charts and Graphics

EXECUTIVE SUMMARY

  • Figure E.1: Self-Grading Overall Segmentation Performance
  • Figure E.2: Average Product' s Market Segmentation Budget
  • Figure E.3: Top Spenders' Average Product' s Market Segmentation Budgets
  • Figure E.4: Grading Segmentation Techniques
  • Figure E.5: Grading Behavioral Segmentation
  • Figure E.6: Annual Reviews and Changes to Segmentation Strategies

MARKET SEGMENTATION BUDGETS, STRUCTURES AND STAFFING

Brand Market Segmentation Budgets

  • Figure 1.1: Average Products' Market Segmentation Budgets
  • Figure 1.2: Percent of Average Brands' Budgets Earmarked for Physician Segmentation
  • Figure 1.3: Average Products' Physician Segmentation Budgets
  • Figure 1.4: Percent of Physician Segmentation Budgets Spent on Outsourced Activities
  • Figure 1.5: Average Products' Consumer Segmentation Budgets
  • Figure 1.6: Company D' s Market Segmentation Budgeting Process
  • Figure 1.7: Company F' s Market Segmentation Budgeting Process
  • Figure 1.8: Company I' s Market Segmentation Budgeting Process
  • Figure 1.9: Percent of Total Segmentation Project Time Spent on Each Step
  • Figure 1.10: Percent of Spending by Segmentation Project Step
  • Figure 1.11: Outsourcing by Project Step
  • Figure 1.12: Outsourcing for Questionnaire Development
  • Figure 1.13: Outsourcing for Data Collection
  • Figure 1.14: Outsourcing for Data Cleansing
  • Figure 1.15: Outsourcing for Data Analysis
  • Figure 1.16: Outsourcing for Segmenting Customer Groups
  • Figure 1.17: Outsourcing for Segmentation Implementation

Market Segmentation Structure

  • Table 1.1: Brand Level Market Segmentation Leadership
  • Table 1.2: Market Segmentation Task Responsibilities
  • Figure 1.18: Outsourcing Percentage by Project Step
  • Figure 1.19: Company D' s Market Segmentation Process: Setting Strategy
  • Figure 1.20: Company D' s Market Segmentation Process: Performing the Work
  • Figure 1.21: Company D' s Market Segmentation Process: Final Approval
  • Figure 1.22: Company D: Communicating Segmentation to the Sales Force
  • Figure 1.23: Company L' s Market Segmentation Process
  • Figure 1.24: Company F' s New Product Market Segmentation Process
  • Figure 1.25: Company F' s In-Line Product Market Segmentation Process
  • Figure 1.26: Average FTEs in Each Major Department Dedicated to Market Segmentation

Market Segmentation Staffing

  • Figure 1.27: Brand Team FTEs Dedicated to Market Segmentation
  • Figure 1.28: Market Research FTEs Dedicated to Market Segmentation
  • Figure 1.29: Sales FTEs Dedicated to Market Segmentation
  • Figure 1.30: Consumer Marketing FTEs Dedicated to Market Segmentation
  • Figure 1.31: Company B FTEs Dedicated to Market Segmentation
  • Figure 1.32: Company E FTEs Dedicated to Market Segmentation
  • Figure 1.33: Company F FTEs Dedicated to Market Segmentation

Small Pharma/Biotech Market Segmentation Budget and Structure Snapshot

  • Figure 1.34: Small Pharma/Biotech Average Brands' Overall Market

Segmentation Budgets

  • Figure 1.35: Small Pharma/Biotech Average Brands' Physician Segmentation Budgets
  • Table 1.3: Small Pharma/Biotech Brand Level Market Segmentation Leadership
  • Table 1.4: Small Pharma/Biotech Market Segmentation Task Responsibilities

European Market Segmentation Budget and Structure Snapshot

  • Figure 1.36: European Average Brands' Overall Market Segmentation Budgets
  • Figure 1.37: European Average Brands' Physician Segmentation Budgets
  • Table 1.5: European Brand Level Market Segmentation Leadership
  • Table 1.6: European Market Segmentation Task Responsibilities

MARKET SEGMENTATION STRATEGIES

Methods of Market Segmentation

  • Figure 2.1: Usage by Segmentation Type
  • Figure 2.2: Grading Segmentation Techniques
  • Figure 2.3: Grading Behavioral Segmentation
  • Figure 2.4: Grading Attitudinal Segmentation
  • Figure 2.5: Grading Volumetric Segmentation
  • Figure 2.6: Grading Psychographic Segmentation
  • Figure 2.7: Grading Demographic Segmentation
  • Figure 2.8: Grading Geographic Segmentation
  • Figure 2.9: Grading Longitudinal Segmentation

Timing Market Segmentation

  • Figure 2.10: Self-Grading of Overall Segmentation Performance

The Future of Market Segmentation

  • Table 2.1: Latent Class Segmentation Versus Traditional Methods

Small Pharma/Biotech Market Segmentation Methodology Snapshot

  • Figure 2.11: Small Pharma/Biotech Companies' Usage of Segmentation Methods
  • Figure 2.12: Small Pharma/Biotechs' Grading of Segmentation Techniques

European Market Segmentation Methodology Snapshot

  • Figure 2.13: European Companies' Usage by Segmentation Method
  • Figure 2.14: European Companies' Grading of Segmentation Techniques

IMPLEMENTING AND REVIEWING MARKET SEGMENTATION STRATEGIES

Implementing Physician Segmentation

  • Figure 3.1: Company D: Communicating Segmentation to the Sales Force
  • Figure 3.2: Company F: Market Research Sells Segmentation
  • Figure 3.3: Company I: Trickle-Down Introduction
  • Figure 3.4: Company U: Sales Force Preparation in the 12 Months Before Launch
  • Figure 3.5: New Rep Training
  • Figure 3.6: Existing Rep Training
  • Figure 3.7: Average Number of Physician Segments Created

Reviewing Market Segmentation

  • Figure 3.8: Times Market Segmentation Reviewed per Year
Back to Top